Morning Overview on MSN
New once-a-day pill slashes bad cholesterol by 57%
An experimental once-daily pill called enlicitide cut LDL cholesterol by 57% in a large Phase 3 clinical trial, a result researchers say could expand options for patients who struggle with existing ...
A Sea-Intelligence analysis of the Ocean Alliance's network update says carriers are “betting on the permanence of the sourcing shift” toward Southeast Asia.
Eli Lilly and Company (NYSE: LLY) is one of the best growth stocks to buy for the next 20 years. On February 18, Eli Lilly ...
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a hormone called glucose-dependent insulinotropic polypeptide (GIP) to “help break ...
This study proposes a cross-species transcriptomic framework to predict vaccine reactogenicity, with implications for preclinical vaccine safety assessment. The findings show that mouse muscle ...
Two local legislators want the East Feliciana Parish Police Jury to adopt a resolution opposing carbon-capture and sequestration projects in Louisiana, including carbon dioxide injection wells and ...
Combination ixekizumab plus tirzepatide outperformed ixekizumab monotherapy for the treatment of both psoriasis and ...
SCULPT & LIFTTM pairs Restylane® Lyft or Restylane® Contour with Sculptra® to help restore a youthful appearance and your ...
Highlights: In-situ carbon injection pilot successfully sequesters 12 tonnes of CO2 at the Crawford Nickel Project Project demonstrates another ...
The proposed bill continues an effort that nearly gained passage last year, but ultimately ran into opposition from Gov. Ned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results